A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA) — Stella
A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(116 sites)
United States
Research Site, Mobile, Alabama
Research Site, Montgomery, Alabama
Research Site, Tucson, Arizona
Research Site, Little Rock, Arkansas
Research Site, Madera, California
Research Site, Torrance, California
Research Site, Washington D.C., District of Columbia